Regulation of toxin production in the pathogenic clostridia

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

The genus Clostridium comprises a large, heterogeneous group of obligate anaerobic, Gram-positive spore forming bacilli. Members of this genus are ubiquitous in the environment and although most species are considered saprophytic, several are pathogenic to both humans and animals. These bacteria cause a variety of diseases including neuroparalysis, gas gangrene, necrotic enteritis, food poisoning, toxic shock syndrome and pseudomembraneous colitis, which in most cases arise as a consequence of the production of potent exotoxins. Treatment options are often limited, underscoring the need for new treatment strategies and novel therapeutics. Understanding the fundamental mechanisms and signals that control toxin production in the pathogenic clostridia may lead to the identification of novel therapeutic targets that can be exploited in the development of new antimicrobial agents.
Original languageEnglish
Pages (from-to)221 - 231
Number of pages11
JournalMolecular Microbiology
Volume91
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

@article{f1b9b1fe5eb740f89c4b57a5ab46e714,
title = "Regulation of toxin production in the pathogenic clostridia",
abstract = "The genus Clostridium comprises a large, heterogeneous group of obligate anaerobic, Gram-positive spore forming bacilli. Members of this genus are ubiquitous in the environment and although most species are considered saprophytic, several are pathogenic to both humans and animals. These bacteria cause a variety of diseases including neuroparalysis, gas gangrene, necrotic enteritis, food poisoning, toxic shock syndrome and pseudomembraneous colitis, which in most cases arise as a consequence of the production of potent exotoxins. Treatment options are often limited, underscoring the need for new treatment strategies and novel therapeutics. Understanding the fundamental mechanisms and signals that control toxin production in the pathogenic clostridia may lead to the identification of novel therapeutic targets that can be exploited in the development of new antimicrobial agents.",
author = "Carter, {Glen P} and Cheung, {Jackie K-L} and Sarah Larcombe and Dena Lyras",
year = "2014",
doi = "10.1111/mmi.12469",
language = "English",
volume = "91",
pages = "221 -- 231",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",
number = "2",

}

Regulation of toxin production in the pathogenic clostridia. / Carter, Glen P; Cheung, Jackie K-L; Larcombe, Sarah; Lyras, Dena.

In: Molecular Microbiology, Vol. 91, No. 2, 2014, p. 221 - 231.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Regulation of toxin production in the pathogenic clostridia

AU - Carter, Glen P

AU - Cheung, Jackie K-L

AU - Larcombe, Sarah

AU - Lyras, Dena

PY - 2014

Y1 - 2014

N2 - The genus Clostridium comprises a large, heterogeneous group of obligate anaerobic, Gram-positive spore forming bacilli. Members of this genus are ubiquitous in the environment and although most species are considered saprophytic, several are pathogenic to both humans and animals. These bacteria cause a variety of diseases including neuroparalysis, gas gangrene, necrotic enteritis, food poisoning, toxic shock syndrome and pseudomembraneous colitis, which in most cases arise as a consequence of the production of potent exotoxins. Treatment options are often limited, underscoring the need for new treatment strategies and novel therapeutics. Understanding the fundamental mechanisms and signals that control toxin production in the pathogenic clostridia may lead to the identification of novel therapeutic targets that can be exploited in the development of new antimicrobial agents.

AB - The genus Clostridium comprises a large, heterogeneous group of obligate anaerobic, Gram-positive spore forming bacilli. Members of this genus are ubiquitous in the environment and although most species are considered saprophytic, several are pathogenic to both humans and animals. These bacteria cause a variety of diseases including neuroparalysis, gas gangrene, necrotic enteritis, food poisoning, toxic shock syndrome and pseudomembraneous colitis, which in most cases arise as a consequence of the production of potent exotoxins. Treatment options are often limited, underscoring the need for new treatment strategies and novel therapeutics. Understanding the fundamental mechanisms and signals that control toxin production in the pathogenic clostridia may lead to the identification of novel therapeutic targets that can be exploited in the development of new antimicrobial agents.

UR - http://onlinelibrary.wiley.com/doi/10.1111/mmi.12469/epdf

U2 - 10.1111/mmi.12469

DO - 10.1111/mmi.12469

M3 - Article

VL - 91

SP - 221

EP - 231

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

IS - 2

ER -